Andrew Wang, MD

Associate Professor

Andrew Wang, MDContact 

Office: (984) 974-0400
Fax:  (984) 974- 8607

Education

M.D., Harvard-Massachusetts Institute of Technology, Division of Health Sciences and Technology, Harvard Medical School, Boston, MA (2004)

Residency - Radiation Oncology, Harvard Radiation Oncology Program, Harvard Medical School (2005–2009) 

BS Biology, Indiana University - Bloomington (1999) Highest Scholastic Distinction

BS Biochemistry, Indiana University - Bloomington (1999) Highest Scholastic Distinction

BA Mathematics, Indiana University - Bloomington (1999) Highest Scholastic Distinction

Academic Honors and Awards

2017     UNC Health Care and Faculty Physicians Award for Carolina Care Excellence

2016     UNC Health Care and Faculty Physicians Award for Carolina Care Excellence

2011     ASTRO Biology Basic Science Research Abstract Award

2010     ASTRO Junior Faculty Basic Science Research Abstract Award

2008     ASTRO Translational Research Meeting Travel Grant

2008     ASTRO Resident Poster Recognition Award (Biology)

2001     Howard Hughes Medical Institute Research Fellowship for Medical Students

2000     Betty and Doris Barrett Scholarship, Harvard Medical School

1998     Thomas Payne Biology Scholarship, Department of Biology, Indiana University

1998     Lewis Bartling Scholarship, College of Arts and Sciences, Indiana University

1998     John Grimes Chemistry Scholarship, Indiana University

1998     Phi Beta Kappa National Honor Society

1998     Blue Key National Honor Society

1998     Herman B. Wells Scholarship (Full tuition merit scholarship), Indiana University

1997     Honors Division Research Scholarship, Indiana University

1997     Alpha Lambda Delta Honor Society Scholarship

1996      Honors Division Faculty Scholarship, Indiana University

1994     National Science Foundation Summer Research Fellowship

Clinical Trials (Active)

  1. IRB #16-0434 (LCCC #1604) Culture of Circulating Tumor Cells Isolated from Cancer Patients with Metastatic Disease. PrincipaI Investigator (PI).
  2. IRB #14-0374 (LCCC #1408) Investigation of Circulating Tumor Cells from Cancer Patients Undergoing Radiation Therapy. Co-Investigator.
  3. IRB #16-2873 (LCCC #1636) Using PROMIS as part of routine clinical care for racially diverse prostate and bladder cancer patients. Co-Investigator.
  4. IRB #14-1999. Biomarker-Based Radiation Dosimetry Project. PI
  5. IRB #15-2169. Exploratory Study of the CytoRADx System as a Biodosimeter. PI

Grants (Active)

  1. R01CA178748 (Wang). NIH/NCI. Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapy. This project aims to develop and evaluate nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapy for cancer. Role: PI.
  2. 1U54CA198999. NCI/NIH Center for Cancer Nanotechnology Excellence. (Huang/Tepper). Nano Approaches to Modulate Host Cell Response for Cancer Therapy – Project 3: Combining Radiotherapy and Nanotechnology for Immunotherapy. To combine concepts from several disciplines:  nanotechnology, immune therapy and radiotherapy, in developing a novel strategy to improve cancer immunotherapy. Role: PI. 
  3. T32 CA196589-01 (Kabanov). Carolina Cancer Nanotechnology Training Program (C-NTP). Role: Co-Director.
  4. CA150391 (Wang). Department of Defense Congressionally Directed Medical Research Programs-Peer Reviewed Cancer Research Program Idea Award with a Special Focus. Tissue-Engineered Cancer Metastasis to Improve the Abscopal Effect and Cancer Immunotherapy in Melanoma. Role: PI.
  5. Accuray (Wang). Investigation of Circulating Tumor Cells as a Biomarkder of Response in Cancer Patients Undergoing Radiosurgery for Oligometastasis(es). To examine whether CTC is a predicative biomarker for radiosurgery response. Role:  PI.

Publications (.pdf)